These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23559405)

  • 1. Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.
    Scaini G; Mello-Santos LM; Furlanetto CB; Jeremias IC; Mina F; Schuck PF; Ferreira GC; Kist LW; Pereira TC; Bogo MR; Streck EL
    Mol Neurobiol; 2013 Dec; 48(3):581-9. PubMed ID: 23559405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
    Scaini G; Comim CM; Oliveira GM; Pasquali MA; Quevedo J; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Bogo MR; Streck EL
    J Inherit Metab Dis; 2013 Sep; 36(5):721-30. PubMed ID: 23109061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.
    Scaini G; Morais MO; Furlanetto CB; Kist LW; Pereira TC; Schuck PF; Ferreira GC; Pasquali MA; Gelain DP; Moreira JC; Bogo MR; Streck EL
    Neurochem Res; 2015 May; 40(5):885-93. PubMed ID: 25681161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
    Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
    Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.
    Scaini G; Morais MO; Galant LS; Vuolo F; Dall'Igna DM; Pasquali MA; Ramos VM; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Soriano FG; Dal-Pizzol F; Streck EL
    Mol Neurobiol; 2014 Oct; 50(2):358-67. PubMed ID: 24390570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats.
    Wessler LB; de Miranda Ramos V; Bittencourt Pasquali MA; Fonseca Moreira JC; de Oliveira J; Scaini G; Streck EL
    Int J Dev Neurosci; 2019 Nov; 78():210-214. PubMed ID: 31330240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
    Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
    Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
    Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
    Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats.
    Wisniewski MS; Carvalho-Silva M; Gomes LM; Zapelini HG; Schuck PF; Ferreira GC; Scaini G; Streck EL
    Metab Brain Dis; 2016 Apr; 31(2):377-83. PubMed ID: 26586008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
    Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
    Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.
    Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL
    Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage in an animal model of maple syrup urine disease.
    Scaini G; Jeremias IC; Morais MO; Borges GD; Munhoz BP; Leffa DD; Andrade VM; Schuck PF; Ferreira GC; Streck EL
    Mol Genet Metab; 2012 Jun; 106(2):169-74. PubMed ID: 22560665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
    Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
    Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
    Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
    Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of branched-chain amino acids alters the balance between pro-inflammatory and anti-inflammatory cytokines.
    Rosa L; Scaini G; Furlanetto CB; Galant LS; Vuolo F; Dall'Igna DM; Schuck PF; Ferreira GC; Dal-Pizzol F; Streck EL
    Int J Dev Neurosci; 2016 Feb; 48():24-30. PubMed ID: 26608891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
    Mescka CP; de Moura Coelho D; Sitta A; Catarino F; Donida B; Rosa AP; Gonzalez EA; Pinheiro CV; Poletto F; Baldo G; Dutra-Filho CS; Vargas CR
    Metab Brain Dis; 2021 Jun; 36(5):1015-1027. PubMed ID: 33620579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.
    Rieger E; de Franceschi ID; Preissler T; Wannmacher CMD
    Neurotox Res; 2017 Nov; 32(4):575-584. PubMed ID: 28612295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease.
    Scaini G; de Rochi N; Jeremias IC; Deroza PF; Zugno AI; Pereira TC; Oliveira GM; Kist LW; Bogo MR; Schuck PF; Ferreira GC; Streck EL
    Mol Neurobiol; 2012 Apr; 45(2):279-86. PubMed ID: 22328136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.